Market Overview

Galmed Pharma (NASDAQ: GLMD)

8.50 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/12/18B. Riley FBRInitiates Coverage OnBuy28.0
7/20/18Raymond JamesInitiates Coverage OnOutperform26.0
7/13/18Stifel NicolausInitiates Coverage OnBuy35.0
7/11/18Cantor FitzgeraldInitiates Coverage OnOverweight59.0
6/13/18Maxim GroupMaintainsBuy30.0
3/15/18Maxim GroupUpgradesBuy
2/14/18Maxim GroupDowngradesHold
11/15/17Roth CapitalInitiates Coverage OnBuy32.0
10/06/17Seaport GlobalInitiates Coverage OnBuy19.0
3/28/16H.C. WainwrightAssumesBuy22.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter